Dublin, Jan. 28, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/kr66q6/pen_injection) has announced the addition of the "Pen Injection Devices" report to their offering.
User-friendly syringe and injection device designs and the availability of an increasing number of drugs in prefilled insertable and disposable cartridges are propelling the growth of pen injection devices for self-administration. The cost of biologicals such as recombinant proteins has created interest in pen injectors to reduce cost and waste associated with the handling of vial-packaged drugs. A second factor is the continued adoption of custom pen designs as a way of differentiating injectables developed for self-administration through product branding. These devices feature one or more user-friendly features to further the product's desirability relative to competing options.
What You Will Learn
- What injectable drugs are supplied in pen injection devices; what are the key market segments, market dynamics and market demographics?
- What are the therapeutic demand drivers and commercial pen products in key product segments?
- What are the design factors, material selection issues, technologies and market development issues?
- How big is the pen injection device market? How fast is it growing? What will it look like in five years?
- Who are the leading device and drug sector participants, their product development activities, business strategies, and corporate alliances and affiliations?
- What is the importance of pharma-device alliances and design partnerships on pen injection device commercialization and market access?
- What is the impact of wirelessly connected pen injection devices on patient care and market growth?
- What are the significant economic, technology, and regulatory factors affecting the market for pen injection devices?
Key Topics Covered:
1. Executive Summary
2. Injectable Drug Sector Market Dynamics
- The Injectable Drug Ecosystem
- Drug Classes and Devices
- Indications and Demand
- The Pen Injection Device Market
- Device Growth Factors
- Biological Drugs Proliferating
- Growth of Self-Administration
- Shifting Demographics
- Device Design Innovation
- Competitive Landscape
- Risk Factors
3. Pen Injection Device Design Factors
- Standardized Pen Platforms
- Custom Pen Designs
- Reusable Pens
- Prefilled Pen Cartridges
- Disposable Pens
- Dual Chamber Pens
- Variable vs Fixed Dosing
- Connected Pens
4. Important Pen-Delivered Drug Classes
- Antibodies
- Anticholinergics
- Dopamine Receptors
- Hematopoietics
- Human Growth Hormone
- Immune Modulators
- Insulins and Antihyperglycemics
- Parathyroid Hormone
- Reproductive Hormones
- Serotonin Antagonists
- Sympathomimetics
5. Pen Injectors - Therapeutic Sector Assessment
- Anemia
- Inflammatory Autoimmune Diseases
- Diabetes
- Emergency Medicine
- Hepatitis
- Hormone Replacement
- Osteoporosis
- Reproductive Health
- Other Commercial Pen Markets & Products
6. Market Factors
- Regulatory Considerations
- Patient Preferences and Compliance
- Managed Care Initiatives
- Private Labeling
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/kr66q6/pen_injection
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infusions and Injectables , Needles and Syringes


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



